Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.

INTRODUCTION Genetic polymorphisms in apolipoprotein genes may be associated with alteration in lipid profile and susceptibility to gallstone disease. AIM To determine the association between apolipoprotein A1 (APOA1) -75 guanine [G] to adenine [A] and +83/84 M2(+/-), MspI) and apolipoprotein C3 (APOC3) (SstI) polymorphisms with gallstone disease. METHODS MspI polymorphisms of the APOA1 gene and SstI polymorphisms of APOC3 were analyzed in DNA samples of 214 gallstone patients and 322 age- and sex-matched healthy controls. All statistical analyses were performed using SPSS version 11.5 (SPSS, USA) and Arlequin version 2.0 (Arlequin, Switzerland). RESULTS The APOA1 -75 G/A polymorphism was significantly associated with gallstone disease. Patients with the GG genotype (P=0.015) and G allele carriers (P=0.004) had a significantly higher risk of gallstone disease (1.087-fold and 1.561-fold, respectively), whereas patients with AA genotypes (P=0.011) and A allele carriers (P=0.004) were protected (OR 0.230 and 0.641, respectively) against gallstone disease. APOA1 +83 M2(+/-) and APOC3 SstI polymorphisms were not associated with gallstone disease. Case-control analysis of haplotypes showed a significant association in males only. G-M2(+)-S1 conferred risk for gallstone disease (P=0.036; OR 1.593, 95% CI 1.029 to 2.464), while A-M2(+)-S1 was protective (P=0.002; OR 0.370, 95% CI 0.197 to 0.695) against gallstone disease. In APOA1(-75)-APOA1(+83) bilocus haplotypes, G-M2(+) was associated (P=0.0001) with very high risk (OR 3.173, 95% CI 1.774 to 5.674) for gallstone disease in males only. APOA1(-75)-APOC3(SstI) haplotypes also showed significant association while APOA1(+83)-APOC3(SstI) haplotypes showed no association with gallstone disease. CONCLUSIONS The APOA1 -75 G/A polymorphism is associated with gallstone disease and shows sex-specific differences. On the other hand, APOA1 M2(+/-) and APOC3 SstI polymorphisms may not be associated with gallstone disease. Haplotype analysis is a better predictor of risk for gallstone disease.

• Publication year

  2007

• Venue

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2007/329342PMID 17853951PMCID PMC2657985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gall Bladder

  2006cited by this paper
• Genetic and environmental influences on symptomatic gallstone disease: A Swedish study of 43,141 twin pairs

  2005cited by this paper
• Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment

  2003cited by this paper
• Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease.

  2003cited by this paper
• Effects of apolipoprotein A‐I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels

  2002cited by this paper
• Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map.

  2001cited by this paper
• MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.

  2000cited by this paper
• Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: a meta-analysis.

  1999cited by this paper
• ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests.

  1999cited by this paper
• The genetics of serum lipid responsiveness to dietary interventions

  1999cited by this paper
• Apolipoprotein A1 Gene Polymorphisms and Risk of Early Coronary Disease

  1998cited by this paper
• Influence of genetic variation at the apo A-I gene locus on lipid levels and response to diet in familial hypercholesterolemia.

  1998cited by this paper
• Apolipoprotein C-III gene variation and dyslipidaemia.

  1997cited by this paper
• Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia.

  1996cited by this paper
• New MspI polymorphism at +83 bp of the human apolipoprotein al gene: Association with increased circulating high density lipoprotein cholesterol levels

  1996cited by this paper
• Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

  1996cited by this paper
• Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease.

  1995cited by this paper
• A polymorphism (G-->A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency.

  1994cited by this paper
• An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.

  1993cited by this paper
• Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII.

  1991cited by this paper
• Plasma lipids and gallbladder disease.

  1991cited by this paper
• Serum lipids and gallstones: a case-control study.

  1990cited by this paper
• G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.

  1990cited by this paper
• Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia.

  1990cited by this paper
• Gallstone growth, size, and risk of gallbladder cancer: an interracial study.

  1989cited by this paper
• Genetic determination of plasma apolipoprotein AI in a population-based sample.

  1989cited by this paper
• Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

  1989cited by this paper
• Cholelithiasis in childhood: a follow-up study.

  1988cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota.

  1987cited by this paper
• Promoter-specific activation of RNA polymerase II transcription by Sp1

  1986cited by this paper
• Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro.

  1985cited by this paper
• Gallstones and risk of gallbladder cancer.

  1985cited by this paper
• Plasma lipids and insulin in gall stone disease: a case-control study.

  1984cited by this paper
• Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile.

  1984cited by this paper
• Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.

  1983cited by this paper
• A protein cofactor of lecithin:cholesterol acyltransferase.

  1972cited by this paper
• Cholelithiasis in childhood. A follow-up study with special reference to heredity, constitutional factors and serum lipids.

  1962cited by this paper
• A catamnestic investigation of Danish twins; a preliminary report.

  1956cited by this paper

• Importance of Polymorphisms in the Gene of Paraoxonase-1 (SNP rs662) and Apolipoprotein A-I (SNP rs670 and rs5069) in Non-Smoking and Smoking Healthy Subjects and Patients with Acute Pancreatitis

  2022cites this paper
• Association of apolipoprotein B XbaI (rs693) polymorphism and gallstone disease risk based on a comprehensive analysis

  2021cites this paper
• Significant Implications of APOA1 Gene Sequence Variations and Its Protein Expression in Bladder Cancer

  2021cites this paper
• Risk Factors for Early Recurrence of Gallstones in Patients Undergoing Laparoscopy Combined With Choledochoscopic Lithotomy: A Single-Center Prospective Study

  2021cites this paper
• Mutations du gène d’apoprotéine B100 au cours des dyslipidémies chez les sujets vivant avec le VIH

  2018cites this paper
• Immunogenetic Basis of Cholecystitis

  2017cites this paper
• Cholelithiasis Following Bariatric Surgery: A New Approach to Deal with

  2017cites this paper
• Polymorphisms in UGT1A1 Gene Predispose South Indians to Pigmentous Gallstones.

  2016cites this paper
• Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease

  2015cites this paper
• Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population of Assam

  2015cites this paper
• Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk

  2015cites this paper
• Serum Concentration and Polymorphisms of Apolipoproteins A-I and B, and Risk of Coronary Artery Disease

  2015cites this paper
• Role of apolipoprotein AI gene polymorphism (G-75A and C+83T) in essential hypertension in Indian population.

  2014cites this paper
• Genetics of gallstone disease.

  2013cites this paper
• Genetics of biliary lithiasis from an ethnic perspective.

  2013cites this paper
• Association of apolipoprotein A1 -75 G/A polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery

  2013cites this paper
• Concept of the pathogenesis and treatment of cholelithiasis.

  2012cites this paper
• Relationship Between Gallbladder Surgery and Ethnic Admixture in African American and Hispanic American Women

  2012cites this paper
• Osteopontin and integrin are involved in cholesterol gallstone formation

  2012cites this paper
• Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts

  2011cites this paper
• Multiple mucin genes polymorphisms are associated with gallstone disease in Chinese men.

  2011cites this paper
• Dissecting the Genetic Heterogeneity of Gallbladder Stone Formation

  2011cites this paper
• ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease.

  2010cites this paper
• The genetic background of gallstone formation: an update.

  2010cites this paper
• ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease.

  2010cites this paper
• Genetics of biliary tract diseases: new insights into gallstone disease and biliary tract cancers

  2008cites this paper
• Gallstone disease: from genes to evidence-based therapy.

  2008cites this paper
• Pathogenesis of gallstone formation: updated inventory of human lithogenic genes

  2008cites this paper